Robert M. Califf, MD-Director, Duke Clinical Research Institute, Professor , Donald F. Fortin, Professor of Cardiology, Duke University Medical Center, Durham, North Carolina
Dr. Califf is Associate Vice Chancellor for Clinical Research, Director of the Duke Clinical Research Institute, Professor of Medicine and Donald F. Fortin Professor of Cardiology in the Division of Cardiology at Duke University Medical Center, Durham, North Carolina, a Fellow and member of the Board of Trustees of the American College of Cardiology, and one of the world’s leading authorities on acute coronary syndromes. As Director of the Duke Clinical Research Institute, Dr. Califf has been responsible for coordinating more than 100 randomized clinical trials. Dr. Califf has contributed more than 600 peer-reviewed journal articles to the medical literature and is an editor of several major textbooks and journals on heart disease, including theheart.org, an online information resource for academic and practicing cardiologists. He is Director of the coordinating center for the Centers for Education & Research in Therapeutics™ (CERTs), a public-private partnership among the Agency for Healthcare Research and Quality, the FDA, academia, the medical products industry, and consumer groups. Dr. Califf also serves on the American College of Cardiology/American Heart Association Task Force on Practice Guidelines for Unstable Angina and Acute Myocardial Infarction.
Matthew T. Roe, MD, MHS-Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
Dr. Matthew Roe is an Associate Professor of Medicine in the Division of Cardiovascular Medicine at Duke University Medical Center and the Duke Clinical Research Institute. Dr. Roe has had numerous leadership roles in prospective registries which have evaluated treatment patterns for acute MI patients in the United States including the CRUSADE registry (2001-2006) and the ACTION Registry ®-GWTGTM(2007-2009). Additionally, Dr. Roe has been the principal investigator for a number of clinical trials evaluating anti-platelet therapies for acute MI patients and reperfusion injury agents for STEMI patients. Dr. Roe serves as a Co-Director of the DCRI Clinical Research Fellowship Program and has an ongoing interest in the training and mentorship of clinical investigators.
Back to top